author-photo

Sudha Visvanathan

Boehringer Ingelheim
Hoffmann-La Roche

93

Papers

5538

Citations

Citation Trend

Filter By

Papers (93) Sort By

Journal Conference Others

POS0687 A RANDOMISED DOSE RANGING, PLACEBO-CONTROLLED, PHASE II STUDY ASSESSING THE EFFICACY AND SAFETY OF BI 655064, AN ANTAGONISTIC ANTI-CD40 ANTIBODY, IN PATIENTS WITH LUPUS NEPHRITIS

2021 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (0)
FC 049A RANDOMISED DOSE RANGING, PLACEBO-CONTROLLED, PHASE II STUDY ASSESSING THE EFFICACY AND SAFETY OF BI 655064, AN ANTAGONISTIC ANTI-CD40 ANTIBODY, IN PATIENTS WITH LUPUS NEPHRITIS

2021 Nephrology Dialysis Transplantation
Show All
- Source
- Cite
- Save
Citations (0)
Erratum: Loss-of-function myeloperoxidase mutations are associated with increased neutrophil counts and pustular skin disease (The American Journal of Human Genetics (2020) 107(3) (539–543), (S0002929720302299), (10.1016/j.ajhg.2020.06.020))

2021 American Journal of Human Genetics
Show All
- Source
- Cite
- Save
Citations (0)
Pustular psoriasis: molecular pathways and effects of spesolimab in generalized pustular psoriasis.

2021 The Journal of Allergy and Clinical Immunology
Show All
- Source
- Cite
- Save
Citations (0)
Phoenix from the flames: Rediscovering the role of the CD40-CD40L pathway in systemic lupus erythematosus and lupus nephritis.

2020 Autoimmunity Reviews
Show All
- Source
- Cite
- Save
Citations (4)
Cell-specific expression of lung disease risk-related genes in the human small airway epithelium

2020 Respiratory Research
Show All
- Source
- Cite
- Save
Citations (9)
Transcriptional insights into pathogenesis of cutaneous systemic sclerosis using pathway driven meta-analysis assisted by machine learning methods.

2020 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (2)
Dysregulation of club cell biology in idiopathic pulmonary fibrosis.

2020 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (3)
Safety, pharmacokinetics and pharmacodynamics of BI 705564, a highly selective, covalent inhibitor of Bruton's tyrosine kinase, in Phase I clinical trials in healthy volunteers

2020 British Journal of Clinical Pharmacology
Show All
- Source
- Cite
- Save
Citations (3)
Fecal microRNAs show promise as non-invasive Crohn´s disease biomarkers

2020
Show All
- Source
- Cite
- Save
Citations (5)